Atara Biotherapeutics Balance Sheet (2013-2026) | ATRA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	123.86M	113.21M	106.08M	101.67M	70.69M	65.11M	92.94M	48.74M	45.90M	64.79M	25.84M	35.09M	31.31M	46.45M	25.03M	13.84M	16.90M	5.74M	8.50M	8.40M
Short-term Investments (Quarter)	249.52M	0.19M	264.98M	0.15M	1.35M	200.29M	149.88M	0.15M	0.15M	0.15M	25.88M	0.15M	3.98M	20.74M	0.15M			7.97M
Cash & Current Investments (Quarter)	373.38M	113.40M	371.07M	101.81M	72.03M	265.40M	242.82M	48.89M	46.04M	64.94M	51.73M	35.23M	35.29M	67.19M	25.18M	13.84M	16.90M	13.71M	8.50M	8.40M
Receivables - Net (Quarter)			0.99M	0.67M	0.64M	0.25M	40.22M	0.40M	0.51M	0.16M	34.11M	35.83M	2.42M	1.33M	1.48M	8.88M		1.91M	1.25M
Receivables (Quarter)			0.99M	0.67M	0.64M	0.25M	40.22M	0.40M	0.51M	0.16M	34.11M	35.83M	2.42M	1.33M	1.48M	8.88M		1.91M	1.25M
Raw Materials (Quarter)							1.21M	1.32M	2.75M	2.42M	2.33M	4.36M	3.64M	1.65M	0.96M
Work In Process (Quarter)							0.37M	4.02M	5.11M	4.17M	7.37M	11.72M	15.11M	12.33M	9.69M
Inventory (Quarter)							1.59M	5.34M	7.86M	6.59M	9.71M	16.08M	18.75M	13.98M	10.65M
Prepaid Assets (Quarter)	18.75M	12.06M	12.37M	11.57M	13.69M	16.05M	10.31M	12.89M	10.16M	9.39M	6.18M	8.13M	5.80M	9.21M	10.12M	4.32M	2.45M	2.81M	2.48M	3.81M
Current Assets (Quarter)	392.32M	369.50M	384.62M	314.39M	346.98M	283.05M	295.08M	224.18M	172.32M	118.70M	101.87M	106.43M	62.41M	91.86M	64.89M	27.18M	24.77M	18.43M	12.21M	12.17M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	51.03M	53.48M	53.78M	9.11M	8.33M	7.27M	6.30M	5.85M	5.35M	4.63M	3.86M	2.99M	2.32M	1.66M	1.29M	0.28M	0.18M	0.15M	0.07M	0.06M
Other Non-Current Assets (Quarter)	1.40M	0.67M	2.37M	51.43M	7.23M		7.02M	6.91M	6.58M	6.29M	4.84M	3.87M	3.61M	3.36M	3.10M	2.84M	0.93M	0.88M	0.89M	0.89M
Non-Current Assets (Quarter)	64.47M	80.43M	83.51M	82.89M	89.14M	85.27M	81.34M	77.90M	74.12M	70.09M	63.63M	58.84M	54.87M	50.85M	44.20M	34.86M	12.13M	11.73M	8.02M	7.82M
Assets (Quarter)	456.79M	449.92M	468.13M	397.28M	436.12M	368.32M	376.42M	302.08M	246.44M	188.79M	165.50M	165.27M	117.28M	142.71M	109.10M	62.04M	36.90M	30.17M	20.23M	20.00M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	12.30M	16.54M	17.37M	11.95M	12.80M	11.30M	6.87M	5.07M	4.14M	6.51M	3.68M	2.85M	5.25M	2.15M	4.37M	1.38M	1.76M	0.32M	0.13M	0.64M
Payables (Quarter)	12.30M	16.54M	17.37M	11.95M	12.80M	11.30M	6.87M	5.07M	4.14M	6.51M	3.68M	2.85M	5.25M	2.15M	4.37M	1.38M	1.76M	0.32M	0.13M	0.64M
Accumulated Expenses (Quarter)	15.32M	19.14M	5.96M	16.38M	16.32M	17.61M	17.66M	6.76M	12.56M	14.43M	19.01M	5.71M	7.27M	8.06M	6.03M	9.50M	4.78M	2.55M	1.80M	0.63M
Other Accumulated Expenses (Quarter)	12.87M	9.27M	13.45M	13.99M	15.12M	22.81M	0.32M	23.77M	20.74M	22.57M	17.36M	0.81M	26.15M	6.08M	0.22M	1.78M	7.67M	4.65M	2.98M	0.04M
Current Leases (Quarter)			0.17M				12.81M	0.83M	0.86M	0.89M	11.26M	0.94M	13.02M	1.01M	1.04M	1.07M	2.24M		1.03M	1.01M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)	40.97M	31.23M	40.76M	50.94M	1.67M	2.66M	8.00M	9.92M	11.95M	11.61M	77.83M	123.15M	107.58M	116.34M	95.09M	15.98M	1.61M	1.01M	0.72M	0.68M
Total Current Liabilities (Quarter)	88.83M	86.15M	105.79M	101.56M	65.69M	72.24M	78.92M	67.88M	74.55M	79.09M	142.23M	180.69M	148.27M	155.98M	134.57M	47.89M	14.56M	18.06M	14.92M	5.64M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)	22.47M	26.84M	55.71M	45.00M	43.33M	42.34M	77.00M	78.04M	75.56M	73.93M	37.56M	0.72M	0.57M	0.47M
Preferred Stock Liabilities (Quarter)
Liabilities from Discontinued Operations (Quarter)				8.33M
Operating Leases (Quarter)	12.18M	24.57M	25.52M	17.45M	64.00M	61.07M	58.06M	54.92M	51.75M	48.51M	45.69M	42.20M	38.70M	35.24M	29.91M	26.71M	15.43M	15.01M	9.35M	9.08M
Other Non-Current Liabilities (Quarter)	1.77M	2.21M	1.50M	0.62M	5.63M	5.55M	5.56M	5.18M	5.02M	4.85M	35.08M	4.40M	4.17M	3.97M	39.01M	3.13M	40.79M	1.76M	42.42M	41.47M
Total Non-Current Liabilities (Quarter)	123.48M	137.57M	187.01M	172.35M	173.02M	175.65M	244.22M	231.95M	233.96M	234.78M	229.66M	259.18M	223.99M	229.28M	167.38M	113.98M	31.15M	65.04M	16.31M	15.84M
Total Liabilities (Quarter)	125.25M	139.78M	188.51M	172.96M	178.64M	181.20M	249.78M	237.12M	238.99M	239.63M	264.74M	263.58M	228.15M	233.25M	206.38M	117.11M	71.94M	66.80M	58.74M	57.31M
Shareholder's Equity
Common Equity (Quarter)	331.54M	310.14M	279.61M	224.32M	257.48M	187.11M	126.64M	64.96M	7.45M	-50.84M	99.23M	-98.31M	-110.87M	-90.54M	-97.28M	-55.07M	-35.04M	-36.63M	-38.50M	-37.31M
Shareholder's Equity (Quarter)	331.54M	310.14M	279.61M	224.32M	257.48M	187.11M	126.64M	64.96M	7.45M	-50.84M	99.23M	-98.31M	-110.87M	-90.54M	-97.28M	-55.07M	-35.04M	-36.63M	-38.50M	-37.31M
Liabilities and Shareholders Equity (Quarter)	456.79M	449.92M	468.13M	397.28M	436.12M	368.32M	376.42M	302.08M	246.44M	188.79M	165.50M	165.27M	117.28M	142.71M	109.10M	62.04M	36.90M	30.17M	20.23M	20.00M
Retained Earnings (Quarter)	0.06M	0.02M	-1464.72M	-1.89M	-2.62M	-1618.45M	-1693.02M	-1.24M	-1838.90M	-1908.70M	-1969.15M	-2000.90M	-2019.95M	-2041.86M	0.01M	-2016.54M		-2018.46M	-2021.87M	-2026.01M
Treasury Shares (Quarter)	5.79M	4.83M	5.59M	8.15M	7.49M	7.93M	6.71M	10.58M	9.76M	8.46M	0.25M	16.47M	0.55M	0.52M	0.41M	0.68M	0.50M	0.28M	0.22M	0.32M

Research Tools

Developers

Atara Biotherapeutics Balance Sheet (2013-2026) | ATRA

Research Tools

Developers

Atara Biotherapeutics Balance Sheet (2013-2026) | ATRA

Create an account

Sign In

Reset Password